Stock screener
All disclosures →
EDGAR →
NVO
Conviction 21HealthcareScan · Thu, Sep 24, 2026Piercing line
Novo Nordisk A S (NVO) closed at $38.63 (+1.19%) on Sep 24, 2026. Its latest daily candle is a piercing line. Price is below its 50-day and below its 200-day moving average. RSI(14) 30, RS Rating 13, -39.6% from its 52-week high, -26.3% year to date. Sector: Healthcare · Drug Manufacturers - General.
NVO$38.63+1.19%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 14.69M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest -63.64%· 4 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price38.63
Change+1.19%
Gap-0.55%
Rel volume1.56×
Avg volume13.32M
Avg $ vol564.17M
SMA 2043.51
SMA 5046.05
SMA 20045.97
Price vs 50-16.13%
Price vs 200-15.98%
MA stackmixed
50/200 cross—
Supertrenddown · 42.25
RSI (14)30
MACD hist-0.57
MACD cross—
Stoch %K / %D8 / 4
ADX (14)25
+DI / −DI15 / 45
RSI divergence—
MACD divergence—
ATR %3.42%
ADR %2.15%
52w high63.98
52w low35.29
From 52w high-39.63%
Above 52w low+9.45%
New 52w highNo
SqueezeOff
Bollinger width24.82%
%B0.05
Donchian pos6.99%
Donchian high48.00
Donchian low37.92
AVWAP (52w high)43.92
vs AVWAP high-12.06%
AVWAP (52w low)43.97
vs AVWAP low-12.16%
OBV trendDown
Chaikin MF (20)-0.21
Today vs 20d1.56×
Avg vol (14d)14.69M
Avg vol (20d)13.32M
Avg $ vol (20d)564.17M
Market cap171.07B
RS Rating13 / 99
RS 3m (vs SPY)-23.41%
RS 6m (vs SPY)-10.50%
RS line new highNo
Trend template0/8
Technical rank27.3
1 week-10.57%
1 month-20.62%
3 months-18.92%
6 months+6.32%
1 year-35.13%
YTD-26.27%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target43.70
Target upside13.14%
Analyst ratingHold
Institutional9.62%
Ent. value171.07B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out3.39B
Employees69.5K
ListedThu, Apr 30, 1981
Free float3.17B
Float %94.9%
Short interest31.65M
Days to cover2.7d
Short volume49.5%
Squeeze score30 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.96 vs $0.82
Last surprise+17.1% beat
Setup gradeD
Conviction21 / 100
Pattern quality—
Tech rank27.3 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmPiercing line
Recent news
- Novo Nordisk (NVO) Falls More Steeply Than Broader Market: What Investors Need to KnowYahoo Finance · Wed, Sep 23, 2026
- Novo Nordisk CEO opens the door to major move for U.S. investorsTheStreet · Wed, Sep 23, 2026
- NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt SlipStocktwits · Wed, Sep 23, 2026
- Novo's Oral Wegovy Just Revealed a Surprising Weight-Loss SignalYahoo Finance · Wed, Sep 23, 2026
- Novo Nordisk open to direct New York listing, CEO saysProactiveinvestors · Wed, Sep 23, 2026
- Huge News For Novo Nordisk FansYahoo Finance · Wed, Sep 23, 2026
- Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trialYahoo Finance · Wed, Sep 23, 2026
- Can Novo's Rare Disease Pipeline Add a New Growth Pillar Beyond GLP-1?Yahoo Finance · Wed, Sep 23, 2026
- Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth TargetsTikr · Wed, Sep 23, 2026
- U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecastYahoo Finance · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in NVO · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Scott Scott Franklin house · R · FL · traded 2026-08-26 | Buy | $1K–$15K | 2026-08-26 | 2026-09-17 | |
 Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $15K–$50K | 2026-03-30 | 2026-07-21 | |
 Lisa McClain house · MI · traded 2025-10-30 | Sell | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · R · MI · traded 2025-09-11 | Buy | $1K–$15K | 2025-09-11 | 2025-10-22 | |
 Marjorie Taylor Greene house · GA · traded 2025-10-15 | Buy | $1K–$15K | 2025-10-15 | 2025-10-20 | |
Lisa McClain house · R · MI · traded 2025-08-04 | Sell | $1K–$15K | 2025-08-04 | 2025-09-12 | |
 Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
Marjorie Taylor Greene house · GA · traded 2025-08-28 | Buy | $1K–$15K | 2025-08-28 | 2025-08-29 | |
Marjorie Taylor Greene house · GA · traded 2025-08-19 | Buy | $15K–$50K | 2025-08-19 | 2025-08-20 |
Insider activity
SEC Form 4 transactions in NVO
No recent insider (Form 4) filings in NVO. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in NVO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.